Australia, May 6 -- Samsung Bioepis Co. Ltd., owns the trademark (2485065) for 'OSPOMYV' till Sept. 24, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceuticals; medicines for human purposes; pharmaceutical preparations; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; biological preparations for medical purposes; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer, tumour diseases and multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer]
Type of Mark: Word
Date of Acceptance: Nov. 8, 2024
Registration Advertised: May 5
For further details contact K&L Gates.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2485065.
Disclaimer: Curated by HT Syndication.
